Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Anti-CD19 therapy may help treat SLE and NMOSD.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Lupus pneumonitis can be misdiagnosed as pneumonia or tuberculosis, so consider lupus in similar cases for proper treatment.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

A fungus ball in the lung can cause coughing up blood in SLE patients.